Myeloma
Inhibition of bone resorption decreased myeloma and tumor progression
Published in Cancer Weekly, February 7th, 2006
According to recent research published in the journal Biochemical and Biophysical Research Communications, "Increased bone resorption is a major characteristic of multiple myeloma and is caused by osteoclast activation and osteoblast inhibition (uncoupling). Myeloma cells alter the local regulation of bone metabolism by increasing the receptor activator of NF-kappa B ligand (RANKL) and decreasing osteoprotegerin expression within the bone marrow microenvironment, thereby stimulating the central pathway for osteoclast formation and activation."
"In...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-02-07)
More Articles from Cancer Weekly
- Breast Cancer
Older age linked to lower risk of lymph node metastasis in breast cancer - Esophageal Cancer
Chemoradiosensitivity of esophageal cancer predicted by serum protein profiling - Non-Hodgkin Lymphoma
Organochlorine chemicals in plasma related to risk of non-Hodgkin lymphoma - Pancreatic Cancer
Proteasome inhibitor MG132 induced apoptosis in human pancreatic cancer cells - Acute Myeloid Leukemia
PAF-R presence on surface of leukemic cells not detected by flow cytometry - Adenocarcinomas
COX-2 is expressed in stromal myofibroblasts surrounding colon adenocarcinomas - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
